Details
Stay ahead of the curve in ATTR-CM management with evolving long-term data
https://ow.ly/ZuxT50YQXB3
This programme explores the relationship between early serum TTR increases and improved patient-reported outcomes, alongside survival and safety data to 54 months.
This programme is supported by an unrestricted educational grant from Bayer.